Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of 56.20 billion. The enterprise value is 66.33 billion.
| Market Cap | 56.20B |
| Enterprise Value | 66.33B |
Important Dates
The last earnings date was Thursday, March 5, 2026.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
| Current Share Class | 129.24M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 16.56% |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 18.35 and the forward PE ratio is 13.91.
| PE Ratio | 18.35 |
| Forward PE | 13.91 |
| PS Ratio | 2.27 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 15.97 |
| P/FCF Ratio | 20.39 |
| P/OCF Ratio | 12.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.99, with an EV/FCF ratio of 24.07.
| EV / Earnings | 21.66 |
| EV / Sales | 2.70 |
| EV / EBITDA | 9.99 |
| EV / EBIT | 14.49 |
| EV / FCF | 24.07 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.46 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.10 |
| Debt / FCF | 5.10 |
| Interest Coverage | 12.06 |
Financial Efficiency
Return on equity (ROE) is 8.92% and return on invested capital (ROIC) is 8.23%.
| Return on Equity (ROE) | 8.92% |
| Return on Assets (ROA) | 4.76% |
| Return on Invested Capital (ROIC) | 8.23% |
| Return on Capital Employed (ROCE) | 9.25% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | 419,390 |
| Profits Per Employee | 51,833 |
| Employee Count | 62,346 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, Merck KGaA has paid 813.67 million in taxes.
| Income Tax | 813.67M |
| Effective Tax Rate | 20.95% |
Stock Price Statistics
The stock price has decreased by -11.93% in the last 52 weeks. The beta is 0.72, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -11.93% |
| 50-Day Moving Average | 148.72 |
| 200-Day Moving Average | 136.74 |
| Relative Strength Index (RSI) | 33.09 |
| Average Volume (20 Days) | 703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of 24.78 billion and earned 3.06 billion in profits. Earnings per share was 7.04.
| Revenue | 24.78B |
| Gross Profit | 14.59B |
| Operating Income | 4.61B |
| Pretax Income | 3.88B |
| Net Income | 3.06B |
| EBITDA | 6.69B |
| EBIT | 4.61B |
| Earnings Per Share (EPS) | 7.04 |
Balance Sheet
The company has 3.92 billion in cash and 14.05 billion in debt, with a net cash position of -10.13 billion.
| Cash & Cash Equivalents | 3.92B |
| Total Debt | 14.05B |
| Net Cash | -10.13B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 33.65B |
| Book Value Per Share | 77.21 |
| Working Capital | 4.92B |
Cash Flow
In the last 12 months, operating cash flow was 4.62 billion and capital expenditures -1.86 billion, giving a free cash flow of 2.76 billion.
| Operating Cash Flow | 4.62B |
| Capital Expenditures | -1.86B |
| Free Cash Flow | 2.76B |
| FCF Per Share | n/a |
Margins
Gross margin is 58.90%, with operating and profit margins of 18.62% and 12.36%.
| Gross Margin | 58.90% |
| Operating Margin | 18.62% |
| Pretax Margin | 15.68% |
| Profit Margin | 12.36% |
| EBITDA Margin | 27.01% |
| EBIT Margin | 18.62% |
| FCF Margin | 11.12% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 35.50% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.93% |
| Earnings Yield | 5.45% |
| FCF Yield | 4.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck KGaA has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 5 |